依替米星联合哌拉西林钠舒巴坦钠治疗肺炎克雷伯杆菌肺炎的效果探究  

Effect of etimicin combined with piperacillin sodium and Sulbactam sodium on Klebsiella pneumonia

作　　者：邹璇[1] Zou Xuan(The Second Department of Respiration,Liuyang People’s Hospital,Liuyang Hunan 410300)

机构地区：[1]浏阳市人民医院呼吸二科,湖南浏阳410300

出　　处：《当代医药论丛》2020年第12期142-144,共3页

摘　　要：目的:探讨用依替米星联合哌拉西林钠舒巴坦钠治疗肺炎克雷伯杆菌肺炎的临床效果。方法:选取2017年9月至2018年9月期间在浏阳市人民医院接受诊治的80例肺炎克雷伯杆菌肺炎患者作为研究对象。将这80例患者随机平均分为Etimicin组(n=40)和Union组(n=40)。对两组患者均使用依替米星进行治疗。在此基础上,为Union组患者加用哌拉西林钠舒巴坦钠进行治疗。然后,比较两组患者治疗的总有效率和不良反应的发生情况。结果:接受治疗后,与Etimicin组患者相比,Union组患者治疗的总有效率更高,P<0.05;两组患者不良反应的总发生率相比,P>0.05。结论:用依替米星联合哌拉西林钠舒巴坦钠治疗肺炎克雷伯杆菌肺炎的临床效果较好,且安全性较高。Objective:To investigate the clinical effect of etimicin combined with piperacillin sodium and Sulbactam sodium in the treatment of Klebsiella pneumoniae.Methods:80 patients with Klebsiella pneumoniae treated in Liuyang People’s Hospital from September 2017 to September 2018 were selected as the study subjects.The 80 patients were randomly and equally divided into the Etimicin group(n=40)and the Union group(n=40).Patients in both groups were treated with etimicin.On this basis,the Union group was treated with piperacillin sodium and sulbactam sodium.Then,the total effective rate of treatment and the occurrence of adverse reactions were compared between the two groups.Results:After treatment,the total effective rate of the Union group was higher than that of the Etimicin group(P<0.05).The total incidence of adverse reactions between the two groups was P>0.05.Conclusion:Etimicin combined with piperacillin sodium sulbactam sodium is effective and safe in the treatment of Klebsiella pneumoniae.

关 键 词：哌拉西林钠舒巴坦钠 依替米星 肺炎克雷伯杆菌肺炎 

分 类 号：R563.1[医药卫生—呼吸系统]